Audion Therapeutics
PrivateLast Round
Grant
Sep 7, 2015
Total Funding Raised
$9.26M
Company Overview
Audion Therapeutics operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Grant round in September 2015.
Audion Therapeutics is a biopharmaceutical company that develops regenerative therapies for the treatment of sensorineural hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Audion Therapeutics Comparables
Compare Audion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Salubritas Therapeutics | 88% | |
| AudioCure Pharma | 86% | |
| Sound Pharmaceuticals, Inc. | 83% |
For institutional investors. Book with your work email.
Audion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 7, 2015 | ||||
| Series B | Sep 7, 2015 | ||||
| Series A | Feb 10, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Audion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inkef Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2014
Eli Lilly and Company led the Series A round.
For institutional investors. Book with your work email.
Audion Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Audion Therapeutics's valuation, stock price, and market status.
Is Audion Therapeutics a public or private company?
Audion Therapeutics is a private company.
What is the current stock price of Audion Therapeutics?
Audion Therapeutics is a private company, so its shares have no public market price. Caplight tracks Audion Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Audion Therapeutics worth (valuation)?
Valuation information for Audion Therapeutics is not publicly available.
Can I buy Audion Therapeutics stock?
Audion Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Audion Therapeutics's last funding round?
Audion Therapeutics's most recent funding round was Grant on September 7, 2015.
Who are the main investors in Audion Therapeutics?
Key investors in Audion Therapeutics include Inkef Capital.
Will Audion Therapeutics IPO soon?
No public IPO plans have been announced for Audion Therapeutics.
How can I track Audion Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Audion Therapeutics's shares on secondary markets.